Third-Party Litigation Financing

Third-party litigation financing (TPLF), or lawsuit funding, is the practice of investors buying an interest in the outcome of a lawsuit, and has become a multi-billion-dollar industry.

The Problem

Third party litigation financing raises ethical concerns by allowing funders to interfere with litigation decisions, which compromises attorney independence and raises costs for litigants.

Economic impacts include:

Hidden Money Pours Into Litigation: Third Party Litigation Funding

“Civil litigation provides a means of resolving disputes between parties, those named in a lawsuit as plaintiffs and defendants. Common law doctrines traditionally prohibited ‘strangers’ to a lawsuit from meddling in litigation or having a financial interest in the outcome due to the potential for litigation abuse. As those principles have fallen by the wayside, outside investors have poured money into civil litigation.”

Read more in the Judicial Hellholes® “Closer Looks” section on third-party litigation financing.

ATRA’s Position

If third party litigation financing continues, regulations should be put in place that increase transparency for litigants and maintains the integrity of the judicial system.

Search Through ATRA Reforms

Search through all of ATRA's reforms around Third-Party Litigation Financing

No related legislation or reform items to display.



Third-Party Litigation Financing News and Press

Explore ATRA's most recent press releases and blogs around Third-Party Litigation Financing

Washington State Lawmakers Should Shine a Light on Secret Lawsuit Investors

This op-ed was published by DC Journal State lawmakers in Washingto...

State Tort Laws Negatively Impacting Economies Outlined for DOJ in ATRA Letter

Today, the American Tort Reform Association provided the Department of Jus...

Oklahoma Named “Tort Reform Trailblazer,” Earns Status as National Leader in New Legislative Report

Today, the American Tort Reform Association named Oklahoma a “Tort Reform ...

Search Resources

Search through all of ATRA's Amicus Briefs, Reports, and Other Resources around Third-Party Litigation Financing
Search All
States
Status
Post Types
Date
Hyundai Motor America v. Applewhite
(Miss., filed September 19, 2016): Arguing that under MS statute, evidence of a plaintiff’s nonuse of his seatbelt is admissible to refute a plaintiff...
Mississippi
  • Court Ruled in Favor of ATRA's Position iconCourt Ruled in Favor of ATRA's Position
Walker v. Ford
(Col., filed September 27, 2016): Arguing that the“risk-benefit” test for strict product liability incorporates the “consumer expectation” test, such ...
Colorado
  • Court Ruled in Favor of ATRA's Position iconCourt Ruled in Favor of ATRA's Position
Cottrell v. Alcon Laboratories
(3rd Cir., filed September 28, 2016): Arguing that the plaintiffs’ speculative claim that they might have paid less for a medication if defendan...
3rd Circuit
  • Court Ruled Against ATRA's Position iconCourt Ruled Against ATRA's Position
Eike v. Allergan
(7th Cir., filed October 18, 2016): Arguing that the plaintiffs’ speculative claim that they might have paid less for a medication if defendants...
7th Circuit
  • Court Ruled in Favor of ATRA's Position iconCourt Ruled in Favor of ATRA's Position
BNSF v. Tyrell
(US., filed October 28, 2016): Arguing that the Montana Supreme Court improperly applied the Daimler personal jurisdiction requirements, which state t...
SCOTUS
  • Court Granted Cert iconCourt Granted Cert
In re Zoloft Litigation
(3rd Cir., filed October 18, 2016): Arguing that an expert cannot premise a causation analysis on a single statistically-significant association when ...
3rd Circuit
  • Court Ruled in Favor of ATRA's Position iconCourt Ruled in Favor of ATRA's Position



The American Tort Reform Association is the nation’s first organization dedicated exclusively to reforming the civil justice system through education and legislative enactment.

To receive occasional updates from ATRA, enter your email address:
By subscribing, you agree to our Privacy Policy and consent to receive updates.
© 2026 ATRA. All rights reserved.